The MarketReader Minute
π Biotech Advances on Broad Market Optimism, Amarin Leads on European Licensing Deal | Biotech Sector Insights
The biotech sector moved higher in line with broader equity gains, supported by easing geopolitical tensions and dovish Fed commentary. Amgen weighed on performance after mixed obesity treatment results, while Vertex saw support from new policy focus on non-opioid pain relief.